Company Profile for BioCardia
3/8/2013 9:03:13 AM
More...
|
Positive Results From BioCardia's Helical Infusion System Phase 1/2 Trial on Ischemic Cardiomyopathy
11/7/2012 7:38:41 AM
More...
|
BioCardia and Juventas Therapeutics, Inc. Announce Phase II Development Program of JVS-100 Delivered With the Helical Infusion System to Treat Heart Failure
3/15/2012 6:20:34 AM
More...
|
BioCardia Says Morph AccessPro Receives FDA Clearance
5/4/2009 7:02:34 AM
More...
|
Thoratec (THOR) Corporation Announces Equity Investment In Emerging Heart Failure Technology
10/19/2005 5:10:38 PM
More...
|